Piramal Pharma Limited announced the successful interim revocation of the closure directions previously issued by the Gujarat Pollution Control Board (GPCB) for its plant at the Dahej Site. Effective immediately, the Company is authorized to resume all manufacturing operations. Piramal Pharma is committed to working with the GPCB to ensure the interim measures are finalized into permanent approvals in due course.
Operational Update Following GPCB Directives
Piramal Pharma Limited has issued an important update regarding its manufacturing facility located at Plot No. D-2/11/A/1, GIDC Dahej, Gujarat, referred to as the ‘Dahej Site’. This follows previous communications dated 4th and 12th February 2026 concerning orders issued under Section 33A of the Water (Prevention and Control of Pollution) Act, 1974.
Interim Revocation Granted
The Company is pleased to confirm that the Gujarat Pollution Control Board (GPCB) has granted an interim revocation of the previously issued closure directions. This decision was conveyed via a letter dated 13th February 2026. As a result of this revocation, Piramal Pharma is now authorized to resume operations at the Dahej Site with immediate effect.
Commitment to Compliance
Piramal Pharma affirmed its continuous commitment to regulatory adherence. The management stated it is actively engaged in ongoing discussions and working diligently on all necessary measures with the GPCB to ensure that these interim directions are successfully converted into final approvals in the near future.
Source: BSE
